Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

After the COVID-19 outbreak, non-evidence based guidelines were published to advise clinicians on the adjustment of oncological treatment during this pandemic. As immune checkpoint inhibitors directly affect the immune system, concerns have arisen about the safety of immunotherapy during this pandem...

Full description

Bibliographic Details
Main Authors: K. de Joode, A. A. M. Oostvogels, C. H. GeurtsvanKessel, R. D. de Vries, R. H. J. Mathijssen, R. Debets, A. A. M. van der Veldt
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
immunotherapy
adaptive immunity
cellular
humoral
kidney neoplasms
cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.627186/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.627186/full

Similar Items